Business Context and Reporting Period
Company: General Electric Company (operating as GE Aerospace)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Following the separation of GE HealthCare (2023) and GE Vernova (April 2024), the Company operates as a standalone global aerospace leader. It is organized into two reportable segments: Commercial Engines & Services (approx. 70% of revenue) and Defense & Propulsion Technologies (approx. 25% of revenue). The Company retains legacy run-off insurance operations and a mortgage portfolio in Poland (Bank BPH).
Key Financial Metrics (2024)
| Metric | 2024 (in millions) | 2023 (in millions) |
|---|---|---|
| Total Revenue | $38,702 | $35,348 |
| Profit (GAAP) | $7,620 | $10,441 |
| Operating Profit (Non-GAAP) | $7,253 | $5,561 |
| Adjusted Earnings (Non-GAAP) | $5,035 | $3,241 |
| Diluted EPS (Continuing Ops) | $6.09 | $8.33 |
| Free Cash Flow (Non-GAAP) | $6,089 | $4,744 |
| Total Borrowings | $19,273 | $20,525 |
| Cash & Equivalents | $13,619 | $15,204 |
Note: Profit margin (GAAP) was 19.7% in 2024, down from 29.5% in 2023. Operating profit margin (Non-GAAP) was 20.7%, up 330 basis points from 2023.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 9% ($3.4 billion) driven by higher equipment pricing, favorable mix, and increased services volume (spare parts and shop visits).
- Earnings Decline (GAAP): Continuing earnings decreased $2.5 billion primarily due to a $5.2 billion reduction in gains on retained and sold ownership interests (GE HealthCare and AerCap), a $0.3 billion goodwill impairment (Colibrium Additive), and higher restructuring charges.
- Adjusted Earnings Growth: Adjusted earnings increased 56% ($1.8 billion) due to a $1.6 billion increase in segment profit and lower Adjusted Corporate & Other operating costs.
- Cash Flow: Free cash flow increased to $6.1 billion, supported by higher net income and lower tax payments, despite working capital growth.
- Debt Reduction: Total borrowings decreased $1.2 billion to $19.3 billion, mainly due to maturities. The Company replaced its $10.0 billion syndicated credit facility with a $3.0 billion revolving facility.
Guidance, Outlook, and Risks
Management Commentary & Outlook
- Commercial Engines: Robust demand for air travel continues. The Company is ramping production of the LEAP engine but faces supply chain constraints limiting deliveries. Internal shop visit output increased.
- Defense: Revenue grew 6% driven by services and improved pricing. Government defense budgets grew in low-to-mid single digits.
- Capital Allocation: The Board authorized a new $15.0 billion share repurchase program. In 2024, the Company repurchased $4.9 billion of stock and paid dividends totaling $1.0 billion.
- Remaining Performance Obligation (RPO): Increased 11% to $171.6 billion, providing visibility into future revenue.
Risks and Contingencies
- Supply Chain: Ongoing material availability and supplier delivery performance issues continue to impact production and delivery schedules.
- Legacy Insurance: Run-off insurance operations (long-term care, life, annuities) carry significant actuarial risks regarding morbidity, mortality, and future premium rate increases. A 5% increase in long-term care incidence rates could adversely impact reserves by $600 million.
- Bank BPH: Ongoing litigation in Poland regarding foreign currency-denominated mortgages. Total estimated losses are $2.46 billion; future adverse developments could require additional capital contributions.
- Legal Settlements: The Company settled the Sjunde AP-Fonden shareholder lawsuit for $363 million in 2024.
- Geopolitical: Risks related to conflicts in Ukraine and the Middle East, trade tensions, and inflationary pressures.
Investor Verification Checklist
- Supply Chain Execution: Verify the Company's ability to meet LEAP engine delivery targets amidst ongoing supply constraints.
- Insurance Reserve Adequacy: Monitor actuarial assumptions for run-off insurance operations, specifically morbidity rates and premium increase approvals.
- Bank BPH Exposure: Track developments in Polish mortgage litigation and potential for additional capital calls beyond the current $2.46 billion estimate.
- Goodwill Impairment: Assess the impact of the Colibrium Additive impairment on future additive manufacturing strategy and valuation.
- Capital Return: Confirm the pace of share repurchases under the new $15 billion authorization and dividend sustainability.